 induct chemotherapi new regimen cisplatin fluorouracil mitomycin hydroxyurea bleomycin carcinoma nasopharynx site head neck region sixty-six patient stage iii IV carcinoma head neck cycl induct chemotherapi cisplatin fluorouracil FU infus bleomycin mitomycin hydroxyurea radiotherapi and/or surgeri men women median age year rang year karnofski perform statu rang primari site nasopharynx patient larynx other patient stage IV diseas respons rate induct chemotherapi complet respons partial respons stabl diseas progress diseas signific differ respons rate patient cancer nasopharynx site surviv month patient cancer nasopharynx surviv primari toxic chemotherapi alopecia leukopenia stomat anemia diarrhea grade IV toxic induct chemotherapi new regimen high respons rate superior FU radiotherapi cur therapi squamou cell carcinoma head neck chemotherapi radiat therapi surviv similar radic surgeri laryng head neck cancer